Analysts expect OnKure Therapeutics, Inc. to report revenue of 159,317.35 for Q4 26, against a range of 154,455.30 to 164,179.40. The most recent reported quarter, Q3 26, came in at 1.51 M, a 828.5% beat against the 162,095.74 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 186,347.35 | 169,407.70 | 173,067.68 | 164,179.40 | 484,902.22 | 513,735.45 | 391,576.66 | 294,472.24 | 504,971.53 | 633,919.19 | 585,160.34 | |||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 154,622.81 | 143,326.88 | 151,123.80 | 154,455.30 | 445,382.78 | 443,869.55 | 341,605.18 | 277,170.88 | 469,825.23 | 555,679.29 | 546,742.42 | |||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 170,485.08 | 156,367.29 | 162,095.74 | 159,317.35 | 465,142.50 | 478,802.50 | 366,590.92 | 285,821.56 | 487,398.38 | 594,799.24 | 565,951.38 |
Analysts expect OnKure Therapeutics, Inc. to report earnings per share of -0.41 for Q4 26, against a range of -0.44 to -0.38. The most recent reported quarter, Q3 26, came in at -0.36, a 14.9% beat against the -0.42 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.10 | -1.37 | -1.19 | -1.14 | -1.09 | -0.99 | -1.11 | -0.31 | -0.36 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.90 | -0.79 | -1.23 | -1.10 | -1.07 | -1.12 | -0.70 | -0.53 | -0.40 | -0.38 | -0.32 | -0.30 | -0.26 | -0.24 | -0.34 | -0.23 | -0.28 | |||||||||
| Low Estimate | -0.96 | -0.89 | -1.37 | -1.32 | -1.21 | -1.30 | -0.82 | -0.61 | -0.44 | -0.44 | -0.34 | -0.36 | -0.28 | -0.28 | -0.40 | -0.27 | -0.34 | |||||||||
| Consensus Estimate | -0.93 | -0.84 | -1.30 | -1.21 | -1.14 | -1.21 | -0.76 | -0.57 | -0.42 | -0.41 | -0.33 | -0.33 | -0.27 | -0.26 | -0.37 | -0.25 | -0.31 |
Pull Wall Street consensus for OnKure Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OKUR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OKUR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OKUR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();